Evidence map›Paper›PMID 39177817›Full record

ArticleMedical molecular morphology2025

Mixed hepatocellular carcinoma and high-grade neuroendocrine neoplasm with ambiguous histopathological features: a case report.

Kentaro Tsuji, Makoto Abe, Saho Wakamatsu, Sayuri Hoshi, Nobuo Hoshi, Chisato Takagi, Noriyoshi Fukushima, Kaoru Hirabayashi

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kentaro TsujiDepartment of Diagnostic Pathology, Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan.
Makoto AbeDepartment of Diagnostic Pathology, Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan.
Saho WakamatsuDepartment of Diagnostic Pathology, Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan.
Sayuri HoshiDepartment of Diagnostic Pathology, Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan.
Nobuo HoshiDepartment of Diagnostic Pathology, Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan.
Chisato TakagiDepartment of Hepato-Biliary-Pancreatic Surgery, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
Noriyoshi FukushimaDepartment of Diagnostic Pathology, Jichi Medical University Hospital, Shimotsuke, Tochigi, Japan.
Kaoru HirabayashiDepartment of Diagnostic Pathology, Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan. khirabay@tochigi-cc.jp.ORCID http://orcid.org/0000-0002-6682-1931

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Well-differentiated neuroendocrine tumor (NET) and poorly differentiated neuroendocrine carcinoma (NEC) are distinct entities with different biological behavior. However, difficult cases showing equivocal morphology have been reported in some organs. Herein, we report a case of primary hepatic neuroendocrine neoplasm (NEN) with ambiguous histopathological features admixed with conventional hepatocellular carcinoma (HCC). A 70-year-old man with untreated chronic hepatitis B underwent left medial sectionectomy because of two incidental liver masses. On pathological examination, one of the resected tumors had intermingling NEN and HCC components. The NEN component consisted of relatively uniform tumor cells proliferating in trabecular, cord-like, or solid patterns with peripheral nuclear palisading. The tumor cells were immunopositive for synaptophysin, chromogranin A, cluster of differentiation 56 (CD56), and focally hepatocyte paraffin 1. p53 showed wild-type expression. The Ki-67 labeling index was 27% at the hot spot. Eleven months after the surgery, he died of a cerebral hemorrhage without evidence of recurrent liver cancer. The intermediate degree of differentiation and the modest proliferative activity can challenge the distinction between NEC and NET G3. While the coexisting HCC indicates NEC rather than NET in a pathogenetic viewpoint, such ambiguous tumor may not be as aggressive as typical NECs.

Indexed as

Carcinoma, HepatocellularCarcinoma, NeuroendocrineLiver NeoplasmsNeuroendocrine TumorsAgedHumansMaleCombined tumorMixed neuroendocrine-non-neuroendocrine neoplasmNeuroendocrine carcinomaNeuroendocrine differentiationNeuroendocrine tumor G3Primary hepatic neuroendocrine neoplasm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.